BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
James Molloy does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 CNSPCNS Pharmaceuticals Inc | Buy | $84.00 | May 2025 | −76.0% | Miss |
 INTSIntensity Therapeutics, Inc. Common stock | Buy | $8.50 | Jan 2025 | −97.8% | Miss |
 VTVTvTv Therapeutics Inc | Buy | $35.00 | Dec 2024 | +87.2% | Miss |
 GOVXGeoVax Labs Inc | Buy | $15.00 | Nov 2024 | −88.9% | Miss |
 INMBINmune Bio Inc | Buy | $20.00 | Oct 2024 | −61.0% | Miss |
 SCLXScilex Holding Company | Buy | $14.00 | Oct 2024 | −54.9% | Miss |
 PXSPyxis Tankers Inc | Buy | $10.00 | Jul 2024 | −38.3% | Miss |
 PEDPEDEVCO Corp | Buy | $1.75 | Jul 2024 | −51.1% | Miss |
 XRTXXORTX Therapeutics Inc | Buy | $14.00 | Jan 2024 | −58.0% | Miss |
 NRSNNeurosense Therapeutics Ltd | Buy | $7.50 | Jul 2023 | −52.6% | Miss |
 ABEOAbeona Therapeutics Inc | Buy | $20.00 | May 2023 | +14.6% | Miss |
 TNXPTonix Pharmaceuticals Holding Corp | Buy | $6.50 | Jan 2023 | −101.8% | Miss |
 AKTXAkari Therapeutics PLC | Buy | $4.00 | Nov 2022 | −60.5% | Miss |
 QNRXQuoin Pharmaceuticals Ltd DRC | Buy | $20.00 | Sep 2022 | −90.4% | Miss |
 CELUCelularity Inc | Buy | $15.00 | Aug 2022 | −96.1% | Miss |
 ENVBEnveric Biosciences Inc | Buy | $1.25 | Jun 2022 | −58.3% | Miss |
 ACHVAchieve Life Sciences Inc | Buy | $25.00 | Oct 2021 | −60.9% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.